Invention Grant
US09266956B2 Methods of inhibiting proliferation of CD40-expressing cancer cells with anti-CD40 antibodies
有权
用抗CD40抗体抑制表达CD40的癌细胞增殖的方法
- Patent Title: Methods of inhibiting proliferation of CD40-expressing cancer cells with anti-CD40 antibodies
- Patent Title (中): 用抗CD40抗体抑制表达CD40的癌细胞增殖的方法
-
Application No.: US14613110Application Date: 2015-02-03
-
Publication No.: US09266956B2Publication Date: 2016-02-23
- Inventor: Yongke Zhang , Guo-Liang Yu , Weimin Zhu
- Applicant: Apexigen, Inc.
- Applicant Address: US CA San Carlos
- Assignee: Apexigen, Inc.
- Current Assignee: Apexigen, Inc.
- Current Assignee Address: US CA San Carlos
- Agency: Cooley LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61K39/00
Abstract:
The present invention provides high affinity anti-CD40 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of cancer and other diseases.
Public/Granted literature
- US20150307616A1 ANTI-CD40 ANTIBODIES AND METHODS OF USE Public/Granted day:2015-10-29
Information query
